Bio-Techne Corp Shares Outstanding 2010-2024 | TECH

Bio-Techne Corp shares outstanding for the quarter ending June 30, 2024 were 0.161B, a 0.67% decline year-over-year.

  • Bio-Techne Corp 2024 shares outstanding were 0.161B, a 0.67% decline from 2023.
  • Bio-Techne Corp 2023 shares outstanding were 0.162B, a 1.38% decline from 2022.
  • Bio-Techne Corp 2022 shares outstanding were 0.164B, a 1.35% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Bio-Techne Corp Shares Outstanding 2010-2024 | TECH

  • Bio-Techne Corp 2024 shares outstanding were 0.161B, a 0.67% decline from 2023.
  • Bio-Techne Corp 2023 shares outstanding were 0.162B, a 1.38% decline from 2022.
  • Bio-Techne Corp 2022 shares outstanding were 0.164B, a 1.35% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$178.8B
Regeneron Pharmaceuticals (REGN)$126.4B
Vertex Pharmaceuticals (VRTX)$124.2B
Gilead Sciences (GILD)$103.4B
Bristol Myers Squibb (BMY)$100.3B
CSL (CSLLY)$97.4B
GSK (GSK)$88.2B
Alnylam Pharmaceuticals (ALNY)$35.2B
Argenex SE (ARGX)$31.2B
BioNTech SE (BNTX)$29.7B
Biogen (BIIB)$28.9B
Moderna (MRNA)$27.7B
Illumina (ILMN)$20.7B
BeiGene (BGNE)$19.2B
Genmab (GMAB)$17.5B
BioMarin Pharmaceutical (BMRN)$13.4B
Vaxcyte (PCVX)$13B
Incyte (INCY)$12.8B
Insmed (INSM)$12.6B
Exact Sciences (EXAS)$12.6B
Sarepta Therapeutics (SRPT)$12B
QIAGEN (QGEN)$10.4B
Legend Biotech (LEGN)$9.3B
Bio-Rad Laboratories (BIO.B)$9.1B
Roivant Sciences (ROIV)$8.9B
Ascendis Pharma (ASND)$8.5B
Intra-Cellular Therapies (ITCI)$7.9B
Exelixis (EXEL)$7.9B
Halozyme Therapeutics (HALO)$7.8B
Repligen (RGEN)$7.6B